Soluble guanylate cyclase as a direct target for pharmacologic mitigation of chronic kidney disease. Jensen M, Jensen BL. Kidney Int 2025;107:391-394.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jensen M, Jensen BL. Soluble guanylate cyclase as a direct target for pharmacologic mitigation of chronic kidney disease. Kidney Int 2025;107:391-394.
PMID: 39984251